Those who applied for
Congratulations to everyone who applied for the free trial.
※ For those who missed the “COVID-19 treatment,” don’t worry. We are going out strong once again.
※ Finally starting. Innotherapy(246960) follow-up stock hits the upper limit on Tuesday ※
Shortly after the report that Johnson & Johnson entered Phase 3 clinical trials, news came out that Novavax is entering Phase 3 trials, causing stock prices to fluctuate!!
According to Bloomberg, Novavax announced it is entering Phase 3 clinical trials. This trial will be conducted over the next 4 to 6 weeks with 10,000 patients aged 18 to 84!!
“I applied and bought every day for 3 days, and I was amazed to see upper limit profits every day. I wondered if it was a dream or reality. It’s truly amazing how this can happen. It’s been about 4 months since I paid the membership fee and received VIP service, and already 56 million KRW has accumulated in my account. I’m really grateful for making money every day. Ah! I’m actively recommending it to my acquaintances as well.” (VIP office worker member Choi Jeong-hoon, 46 years old)
▶▶ “September 29 upper limit” is only available until today and then closes.
[Receive ‘annual 2 billion vaccine production biggest beneficiary’ related stocks!] ▶Receive stocks◀
Think of this as the last chance. If you miss this opportunity, you have to give up.
Exactly on “September 29” it will explode! Don’t miss it and regret it, buy at least 100,000 KRW worth!
▶▶ Only 10 people will be given. “Tuesday upper limit”! ▶Receive now◀
※ First-come, first-served for 10 people! Both early and late rounds are over. The hero of the final injury time winning goal ※
[Today’s stocks of interest]
#Cube&Company #Daewoong #Celltrion #AprogenPharmaceutical #MyungmoonPharmaceutical
※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
